Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%)
< Home < Back

Dr. Reddy's Laboratories eyes to launch Sputnik V vaccine for COVID-19 under EUA in March

Date: 01-02-2021

Dr. Reddy's Laboratories has expected Russia's COVID-19 vaccine Sputnik V, under phase 3 trials being conducted by the city-based drug maker, to be launched in India through Emergency Use Authorisation (EUA) by March this year.

The ongoing trial was expected to be completed by February after which it would approach the Drug Controller General of India (DCGI) for EUA and based on its approval the vaccine could be launched in March. The company partnered with Russian Direct Investment Fund (RDIF) in September to conduct the clinical trials of the Sputnik V vaccine and for its distribution rights in India.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.